Evidence map›Paper›PMID 39195190›Full record

ArticleDiseases (Basel, Switzerland)2024

Left Ventricular Reverse Remodeling after Surgical Aortic Valve Replacement for Aortic Regurgitation-An Explorative Study.

Zsuzsanna Arnold, Alexander Elnekheli, Daniela Geisler, Thomas Aschacher, Verena Lenz, Bernhard Winkler, Reinhard Moidl, Martin Grabenwöger

Abstract read
In one paragraph

Article in Diseases (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Left Ventricular Molecular Signature in Chronic Aortic Regurgitation.International journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zsuzsanna ArnoldDepartment of Cardiovascular Surgery, Clinic Floridsdorf, 1210 Vienna, Austria.ORCID 0000-0003-2557-7976
Alexander ElnekheliMedical Faculty, Sigmund Freud University, 1020 Vienna, Austria.
Daniela GeislerDepartment of Cardiovascular Surgery, Clinic Floridsdorf, 1210 Vienna, Austria.
Thomas AschacherDepartment of Cardiovascular Surgery, Clinic Floridsdorf, 1210 Vienna, Austria.ORCID 0000-0003-3373-8194
Verena LenzDepartment of Cardiovascular Surgery, Clinic Floridsdorf, 1210 Vienna, Austria.
Bernhard WinklerDepartment of Cardiovascular Surgery, Clinic Floridsdorf, 1210 Vienna, Austria.
Reinhard MoidlDepartment of Cardiovascular Surgery, Clinic Floridsdorf, 1210 Vienna, Austria.
Martin GrabenwögerDepartment of Cardiovascular Surgery, Clinic Floridsdorf, 1210 Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe timing of treatment for chronic aortic valve regurgitation (AR), especially in asymptomatic patients, is gaining attention since less invasive strategies have become available. The aim of the present study was to evaluate left ventricular reverse remodeling after aortic valve replacement (AVR) for severe AR.

methodsPatients (n = 25) who underwent surgical AVR for severe AR with left ventricular ejection fraction (LVEF) less than 55% were included in this study. Preprocedural and follow-up clinical and echocardiographic measurements of LVEF and left ventricular (LV) diameters were retrospectively analyzed.

resultsMean LVEF increased significantly following surgical AVR (

conclusionsWe demonstrated significant LV reverse remodeling following AVR for AR. However, more data are needed on LV functional and geometrical improvement comparing the different types of valve prostheses to provide an optimal treatment strategy.

Indexed as

aortic regurgitationbiological valvemechanical valvereverse remodeling

Identifiers

PMID39195190
PMCPMC11353267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.